136 related articles for article (PubMed ID: 12934484)
1. [Invasive aspergillosis in immunocompromised patients].
Kliasova GA; Petrova NA; Galstian GM; Gotman LN; Vishnevskaia ES; Sysoeva EP; Khoroshko ND; Mikhaĭlova EA; Parovichnikova EN; Isaev VG
Ter Arkh; 2003; 75(7):63-8. PubMed ID: 12934484
[TBL] [Abstract][Full Text] [Related]
2. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
3. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
5. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
9. [Possible sources of aspergilla infection in a hematological hospital].
Petrova NA; Kliasova GA
Ter Arkh; 2005; 77(7):71-7. PubMed ID: 16116914
[TBL] [Abstract][Full Text] [Related]
10. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic pneumonia caused by Aspergillus niger: is oral cleansing with amphotericin B efficacious in preventing relapse of allergic pneumonitis?
Ogawa H; Fujimura M; Tofuku Y; Kitagawa M
J Asthma; 2009 Feb; 46(1):95-8. PubMed ID: 19191146
[TBL] [Abstract][Full Text] [Related]
13. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
[TBL] [Abstract][Full Text] [Related]
14. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host.
Polat G; Urpek G; Yilmaz U; Büyükşirin M; Karadağ Polat S; Uluer S; Tibet G
Respirology; 2005 Jun; 10(3):393-5. PubMed ID: 15955156
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
Bowden R; Chandrasekar P; White MH; Li X; Pietrelli L; Gurwith M; van Burik JA; Laverdiere M; Safrin S; Wingard JR
Clin Infect Dis; 2002 Aug; 35(4):359-66. PubMed ID: 12145716
[TBL] [Abstract][Full Text] [Related]
17. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
18. [Aspergillus lung pathology in transplant patients].
Kaiser L; Rochat T
Rev Mal Respir; 1996 Nov; 13(5 Suppl):S93-101. PubMed ID: 9011916
[TBL] [Abstract][Full Text] [Related]
19. [Invasive pulmonary aspergillesis].
Kliasova GA; Petrova NA; Parovichnikova EN; Gotman LN; Isaev VG; Mikhaĭlova EA; Ustinova EN; Khoroshko ND; Vishnevskaia ES; Kremenetskaia AM; Kravchenko SK; Kaplanskaia IB; Kokhno AA; Ptitsin SA; Liubimova LS; Mendeleeva LP; Mitish NE; Galstian GM; Ryzhko VV; Tochenov AV; Savchenko VG
Ter Arkh; 2005; 77(7):65-71. PubMed ID: 16116913
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
